| 1 |
35237863 | A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial. | 2022 Mar 2 |
1 |
| 2 |
30380116 | Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses. | 2019 Jul 1 |
9 |
| 3 |
31278194 | A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD. | 2019 Aug |
1 |
| 4 |
31668632 | Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease. | 2019 Dec |
1 |
| 5 |
29181658 | Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency. | 2018 Aug |
2 |
| 6 |
29874654 | Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients. | 2018 |
4 |
| 7 |
26813504 | [Phosphate metabolism and iron deficiency]. | 2016 Feb |
1 |
| 8 |
25468387 | A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5. | 2015 May |
2 |
| 9 |
25832833 | [Iron, aluminum, and lanthanum-based drugs for treatment of hyperphosphatemia]. | 2015 |
2 |
| 10 |
26551233 | Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency. | 2015 |
4 |
| 11 |
24408120 | Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD. | 2014 Mar |
2 |